All articles by Daniel Garrun

Micro-machines: nanotech offers new possibilities for disease detection and drug delivery

Molecular machines nearly 4,000 times narrower than a human hair could soon be navigating their way through our bodies, performing…
Using shark antibodies to treat Alzheimer’s disease

Alzheimer’s disease, the most common form of dementia, is a major area of unmet need. With one in six people…
India’s drug price overhaul: a question of balance

India’s policy of placing price caps on pharmaceutical products is set for a shake-up, as the government considers dismantling the…
How rebuilding entire immune systems could be the key to curing MS

A pioneering treatment, which involves destroying a patient’s immune system before replacing it with a new one created from their…
Taking the sting out of painkillers: how close are we to ending the opiate epidemic?

Pain relief sits at the cornerstone of any modern healthcare system. Though the precise incidence is unclear, it is estimated…

Psilocybin vs. depression: London study overcomes obstacles to show encouraging results

Magic mushrooms might sound like an unlikely depression drug. Associated more with the 1960s' counterculture than with modern medical science,…
How text mining is opening up clinical research

The amount of information that can be accessed at the click of a button today is staggering, and its potential…
Could clinical trial data go mobile?

Over the past few years, mobile health (mHealth) technology has advanced at a rate of knots. From wearable fitness trackers…
Gut Bacteria: manipulating the microbiome

In recent years, the human microbiota has attracted attention as one of the most intriguing and underexplored areas of medical…
Groundbreaking medicine: the T-cell revolution

On 16 February 2016, the headlines were unambiguous: "T-cell therapy offers lasting cure prospects"; "New cancer therapy could give hope…